Japan focus: Daiken Biomedical's Japanese patent, B. breve benefits, Meiji and Albion's collaboration, CURE's debut
This round-up features Daiken Biomedical’s Japanese patent, positive effects of probiotic strain Bifidobacterium breve M-16V, Meiji and Albion’s collaborative launch, Asahi-funded study on yeast mannan, and CBD brand CURE’s Japan debut plans.
Source: dairyreporter.com